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impact on mortality, when the patient did not receive thmmbolytic treatment. 
Patients who received thrombolytic treatment had benefit of early admission 
and thrombelysis as long as three years pest-AML 
~ Clinical Charecfarletics Predictors of Mortality as 
in Poet-Myocardial infarction Patients 
R.T. van Domburg, J.W. Deckers, A.J. Azar, P.RM.M. van Bergen, 
J.J.C. Jonkar. Univers#y HoSl~ita/ Dijkzigt and Erasmus University 
Rotterdam, The Netherlands 
We investigated the relative contribution of variables from the history of the 
patient at admission and additional information obtained uring hospitaliza- 
tion in 3404 pest-myocardial infarction patients (80% male). Included were 
patients with at least two of the following criteria: persistent chestpain typical 
for MI, at least twice the normal enzyme fimif and ST-T changes on the 
electrocardiogram. Excluded were patients with indication for oral anticoag- 
ulant treatment, increased bleeding tendency, cardiomyopathy, anticipated 
revasculadsation, malignant disease, mental disorder and pregnancy. 
Patients were admitted from 1986 till 1992. After a median follow-up of 
3 years (0.5-6 years) 359 patients had died. In 77%, the cause of death 
was cardiovascular. Data on infarct size were not available. Multivariate Cox 
regression was performed on both history and hospitalization variables. 
HR and 95% CI History History + hospitalization 
Age/year 1.07 1.06--1.08 1.07 1.06-1.08 
Diabetes 1.39 1.01-1.91 
History of angina 1.33 1.04-1.71 
Previous infarction 1.68 1.26-2.23 1.62 1.22-2.15 
Hospitalization History + hospitalization 
Heartha'~JureJnhospJte] 2.71 1.97-3.72 2.05 1.80-2.80 
VTNF > 24 hour 1.50 0.90-2,48 1,57 0.97-2.55 
Thrombolysis 0.48 0.35-0.67 0.74 0.54--1.00 
Beta-blocker 0.60 0.48-0,76 0.69 0.55-0.63 
Prediction of outcome improved when additional information was added 
to the model. Relative simple clinical characteristics, as shown in the table, 
contributed significant in the prediction of mortality. 
These data illustrate the importance of an integrated approach to outcome 
prediction in pest-myocardial infarction patients and provide a minimum set 
of variables that should be included when the relative worth of additional 
prognostic tests is considered in these patients. 
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Numerous indices of global and regional left ventricular function have been 
used to stratify early or intermediate t rm mortality prognosis following acute 
myocardial infarction (AMI). In a large and unique population, the GUSTO-1 
Angiographlc Trial, 2 year mortality data is now complete with only 115/2431 
(4.7%) patients lost to follow-up. We determined the relative contribution of 
venfficulographic indices obtained within 5-7 days of the Index AMI to 2 
year mortality by multivariate logistic regression analysis in 1808 patients 
with complete anglogrophic and 2 year mortality data sets. Angiogrophlc 
variables included ejection fraction (El=), end systolic volume index (ESVI), 
end-diastolic volume index (EDVI), regional extent of infarction (# of chords) 
and regional infarct severity (SDIchord). Variables were entered into the mul- 
tivariate model in a stepwlsa manner eflective of their blolo"dc significance. 
EF, ESVI, EDVI, regional extent and severity of Infarctior, ,ere significant 
determinants of 2 year mortality by univariate analysis (all ~, < 0.0001). In- 
dependent determinants of 2 year mortality were: (RR = relative risk; CI = 
confidence limits) 
RR 95% CI 
EF (< 40, > 40) 2.8 (1.8,4,3) 
# Chords (< 16, • 16) 1.9 (1.3, 3.0) 
ES,,Vi (< 34, > 34) 1.8 (1.2, 2.7) 
Conclusions: 1. This prospective study illustrates the relative contribution 
of global and regional indices of ventricular function to long term mortality 
following AMI. 2, Global ventficular function and the extent of regional van- 
tricular dysfunction i  the infarct zone are each potent independent predictors 
of long term (2 year) prognosis in AML 
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[ 1010-1091 Predictors and Late Sequelae of Distal 
Embolizetion In Patients With Cmetlne Klnsse 
Elevation Following Elective PTCA 
Thomas Q, Kong, Sheridan N. Meyero, Mlchele A, Parker, Michael D. EIliott, 
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We have previously shown that distal embolizatton (DE) at PTCA frequently 
results in croatine kinase (CK) elevation (99% incidence). To identify predic- 
tors of distal embolization, anglographlc data from patients with CK elevation 
after elective PTCA using DCA, TEC, or balloon were evaluated. Logistic 
regression analysis was employed to determine device and lesion character- 
Istics as well as their interactions which were predictive of distal embelization. 
Results: Elective PTCA was performed on 503 lesions in 237 patients 
who developed CK elevation after PTCA (62 :E 11 yrs; 70% male; 2.1 :E 1.3 
lesions per patient). DE was observed following treatment of 75 lesions. 
Un.. ~adate DE No DE p Multivariate p 
TEc (%) 32 9 <0.00001 TEC O.O0t 
Thrombus (%) 32 10 <0.00001 DGA 0,006 
DCA (%) 31 11 <0.00001 Thrombus 0.0003 
Initial stenosis (~.) 91 ± 9 86 ± 13 <0.01 
Total occlusion (%) 15 7 < 0.04 
Init. TIMI flow < 3 (%) 40 24 <0,03 
Vein graft PTCA (%) 31 10 <0.00001 
At 3.5 -4- 2.3 years follow-up, cardiac death occurred in 15/69 (22=/0) of 
patients with vs. 19/168 (11%) without DE (p < 0.04). 
Conclusions: 1) The use of DCA or TEC is strongly associated with distal 
embolization. 2) Thrombus is the only angiographic lesion characteristic that 
is independently associated with DE. 3) DE is predictive of excessive late 
cardiac death. 
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Glycoprotein lib/Ilia receptor inhibition during coronary interventions lint) has 
been associated with excess vascular access site (VAS) complications. We 
assessed VAS complications from tot with a new glycoprotsin lib/ilia receptor 
inhibitor (Integrolin) in the IMPACT II trial. 4010 patients (pts) undergoing Int 
were randomized to placebo vs bolus/low dose 24 hour Infusion vs bolus/high 
dose 24 hour infusion of Integrolin. Heperin during Int was weight-adjusted 
and was stopped 4 hrs before sheaths were pulled. 
Results: Vascular surgical repair was rare (1"/o) and did not correlate with 
treatment, artedat sheath size, time to sheath removal, or use of a venous 
sheath. 79% of all moderate-severe bleeds occurred at the VAS. Moderote- 
severe VAS bleeding occurred in more Integrolin-treated pts (8,8% vs 5.3% 
placebo pts, p =, 0.0001), pts with venous sheath (8.4% vs 5.7=/0 no sheath, p 
= 0.002) and pts with sheath removed > 12 h (9.6% vs 5.6% sheath >_. 12 h, 
p ,= 0.0001). Procedural ACT was higher (398 ± 142 vs 388 + 185 seconds, 
p = 0,02) In modemmte-severo VAS bleed pts than in none/minor VAS bleed 
pts, A trend toward more rnodemta-severo VAS bleeding was observed with 
larger sheath size (p = 0,08). 
Conclusions: 1) Integrciin increases moderata-severo VAS bleeding. 2) 
VAS bleeding may be reduced by early sheath removal and avoiding venous 
sheaths. 3) Early sheath removal during inhibition of platelet aggregation by 
Integrciln is safe and may be a preferred strategy. 
11010-111 I Reuse of FrCA Catheters Is Not Associated With 
" Increased In-hospital Complications 
Kocn-Hou Mak, Mark J, Eisenberg, Sylvaln Plants, Bradley H, Strauss, 
Kdstopher L Aphead, Eric J. TopoL The Cleveland Clinic Foundation, 
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Although catheter ouse may reduce cost, a recent prospective study in 693 
patients compared a center that rouses PTCA catheters with a center that 
uses only new catheters uggested that potential savings may be offset by 
increased in-hospital complications. To examine this issue, we roanalyzed 
